Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Partners in Hope, Lilongwe, Malawi.
J Int AIDS Soc. 2024 Sep;27(9):e26354. doi: 10.1002/jia2.26354.
People living with HIV have high rates of hypertension. Integrated HIV and hypertension care with aligned multi-month dispensing of medications (MMD) could decrease the burden of care for individuals and health systems. We sought to describe hypertension control and evaluate its association with different durations of MMD among Malawian adults receiving integrated care with aligned dispensing of antiretroviral therapy (ART) and antihypertensive medication.
We conducted a cross-sectional survey and retrospective chart review of adults (≥18 years) receiving integrated HIV and hypertension care on medications for both conditions for at least 1 year, with aligned MMD at seven clinics in Malawi. Data were collected from July 2021 to April 2022 and included socio-demographics, clinical characteristics, antihypertensive medications and up to the three most recent blood pressure measurements. Bivariate analyses were used to characterize associations with hypertension control. Uncontrolled hypertension was defined as ≥2 measurements ≥140 and/or ≥90 mmHg. Chart reviews were conducted for a random subset of participants with uncontrolled hypertension to describe antihypertensive medication adjustments in the prior year.
We surveyed 459 adults receiving integrated care with aligned dispensing (58% female; median age 54 years). Individuals most commonly received a 3-month aligned dispensing of ART and antihypertensive medications (63%), followed by every 6 months (16%) and every 4 months (15%). Hypertension control was assessed in 359 respondents, of whom only 23% had controlled hypertension; 90% of individuals in this group reported high adherence to blood pressure medications (0-1 missed days/week). Control was more common among those with longer aligned medication dispensing intervals (20% among those with 1- to 3-month dispensing vs. 28% with 4-month dispensing vs. 40% with 6-month dispensing, p = 0.011). Chart reviews were conducted for 147 individuals with uncontrolled hypertension. Most had high self-reported adherence to blood pressure medications (89% missing 0-1 days/week); however, only 10% had their antihypertensive medication regimen changed in the prior year.
Uncontrolled hypertension was common among Malawian adults receiving integrated care with aligned MMD and was associated with shorter refill intervals and few antihypertensive medication escalations. Integrated care with aligned MMD is promising, but further work is needed to understand how to optimize hypertension outcomes.
HIV 感染者高血压发病率较高。将 HIV 和高血压的综合护理与药物的多(月)次调配(MMD)相结合,可以减轻个人和卫生系统的护理负担。我们旨在描述高血压的控制情况,并评估其与马拉维接受抗逆转录病毒治疗(ART)和降压药物联合调配的成年人中不同 MMD 持续时间之间的关系。
我们对在马拉维的七个诊所接受至少一年针对两种疾病的综合 HIV 和高血压护理以及药物联合 MMD 的成年人(≥18 岁)进行了横断面调查和回顾性病历审查。数据收集于 2021 年 7 月至 2022 年 4 月,包括社会人口统计学特征、临床特征、降压药物以及最近三次血压测量结果。采用单变量分析来描述与高血压控制相关的因素。未控制的高血压定义为≥2 次测量值≥140 和/或≥90mmHg。对未控制高血压的随机参与者子集进行病历审查,以描述过去一年中降压药物的调整情况。
我们调查了 459 名接受联合调配的综合护理的成年人(58%为女性;中位年龄 54 岁)。大多数人接受的是每 3 个月一次的联合调配 ART 和降压药物(63%),其次是每 6 个月一次(16%)和每 4 个月一次(15%)。在 359 名接受评估的高血压患者中,只有 23%的患者血压得到了控制;在这组患者中,90%的人报告高依从性(每周漏服 0-1 天)。药物调配间隔时间较长的患者血压控制情况更常见(3 个月调配组的控制率为 20%,4 个月调配组为 28%,6 个月调配组为 40%,p=0.011)。对 147 名未控制高血压患者进行了病历审查。大多数人报告高依从性(每周漏服 0-1 天的比例为 89%);然而,在过去一年中,只有 10%的人调整了降压药物治疗方案。
在接受联合 MMD 药物调配的马拉维成年人中,未控制的高血压很常见,与较短的药物调配间隔时间和较少的降压药物升级有关。结合 MMD 的综合护理很有前景,但需要进一步研究以了解如何优化高血压治疗效果。